CSIMarket


Amerisourcebergen Corp  (ABC)
Other Ticker:  
 


 

Amerisourcebergen Corp

ABC's Financial Statements and Analysis



Amerisourcebergen Corp reported in III. Quarter net earnings per share of $1.92 an increase by 37.14 % year on year from $1.40 and decline of -25.87 % from $2.59 earned in II. Quarter (Mar 31 2022).


III. Quarter
Earnings Per Share Revenues
$ 1.92 $  60,065 Mill
$+0.52     +37.14 % $+6,659M     +12.47 %



Amerisourcebergen's Revenue rose by 12.47 % in III. Quarter (Jun 30 2022) year on year, to $60,065 million and advanced by 4.06 % sequentially.


Amerisourcebergen is Expected to report next financial results on May 03, 2023.

More on ABC's Income Statement





       
  • Pharmaceutical Distribution 9.88% Y/Y,
• Other 147.13% Y/Y
   
     


ABC's Segments

Amerisourcebergen's net income of $363.203 million in III. Quarter increased by 22.93 % from net earnings of $295.448 million achieved in III. Quarter a year ago.

Sequentially net earnings fell by -34.59 % from net income of $555.245 million realized in previous quarter.

More on ABC's Growth



Amerisourcebergen Income Growth by Division
• Pharmaceutical Distribution 5% Y/Y,
• Other 129.74% Y/Y Inventories grew by 5.51 % to $15,823 million from III. Quarter a year ago, sequentially inventories rose by 1.99 %. In III. Quarter company's net cash and cash equivalents decreased by $-171 million, capital expenditures grew by -6.90%, to $-113 millions compare to same quarter a year ago and rose by -12.54% from II. Quarter (Mar 31 2022).

More on ABC's Cash flow Statement


Amerisourcebergen Corp payed out dividend of $1.82 per share in last 52 weeks representing 20.87 % of net earning per share in trailing twelve-month period.

During the same period Amerisourcebergen Corp earned $ 12.04 cash per share, on a free-cash flow basis 138.03 % of net earning per share.